The Peptide Index — Evidence, Community Signal & Regulatory Status | BIOHACKING. EVOLVED.
OUTCOME INTELLIGENCE · COGNITION

Cognition

Feeling calmer, sharper or more focused is not the same as proven cognitive enhancement.

Cognition includes attention, memory, executive function, mood, stress response and subjective mental clarity. These outcomes overlap, but they are not interchangeable—and an anxiolytic or mood effect should not automatically be labeled a nootropic effect.

The question that matters
Was a meaningful cognitive or clinical outcome measured in humans with a characterized product?

Subjective focus, reduced anxiety, memory performance and executive function are different endpoints. The evidence should say which one actually changed.

01 / DEFINE THE OUTCOME

Cognition is not one thing.

The word “cognition” can hide very different biological and psychological outcomes. Separating them makes the evidence much easier to judge.

AttentionThe ability to sustain or direct focus toward relevant information.
MemoryEncoding, storage and retrieval—often measured very differently across studies.
Executive functionPlanning, inhibition, working memory and flexible problem solving.
MoodEmotional state is clinically meaningful but should not be confused with improved cognitive performance.
Stress & anxietyReduced anxiety can improve perceived focus without proving a direct nootropic effect.
Sleep-dependent cognitionMemory, vigilance and next-day performance can shift simply because sleep quality changes.
02 / THE LANDSCAPE

Small evidence bases. Big interpretation problems.

Neuropeptide interest is high, but accessible high-quality human evidence is uneven and often formulation-, population- or geography-specific. Selank is the clearest example of why “promising” should not become “proven.”

Selank

Investigational in U.S.

A synthetic peptide developed in Russia and studied for anxiolytic and cognitive effects, with a limited Western clinical evidence base.

Human Evidence●●○○○
Preclinical●●●○○
Interesting, but evidence base is limited
Explore profile →

Oxytocin

FDA-approved drug in obstetric settings

An endogenous peptide hormone and established drug in obstetric medicine, also widely studied in social, behavioral and metabolic neuroscience.

Human Evidence●●●●●
Preclinical●●●●●
Oversimplified
Explore profile →

Delta Sleep-Inducing Peptide (DSIP)

Experimental

A small peptide historically studied in sleep and stress biology, with inconsistent and limited human evidence.

Human Evidence●○○○○
Preclinical●●○○○
Evidence is weak and inconsistent
Explore profile →

Kisspeptin-10

Investigational / compounded interest

A peptide that activates the reproductive hormone axis and has been studied in humans for fertility and neuroendocrine applications.

Human Evidence●●●○○
Preclinical●●●●○
Biology is real — consumer claims are broader
Explore profile →

Evidence scores are editorial orientation, not cognitive-performance rankings. Anxiety, mood, sedation and sleep effects should not be automatically reclassified as cognitive enhancement.

03 / COMMUNITY SIGNAL

“Calm focus” is the phrase that collapses several outcomes into one.

Selank and related neuropeptide discussions often combine anxiety relief, subjective focus and cognitive enhancement into a single story. Community reports can be useful for tracking what people notice—but they are especially vulnerable to expectation effects and endpoint drift.

Subjective clarity ≠ measured cognition. Community Signal can show recurring themes such as calmness, focus or sleep effects. It cannot establish improved memory, attention or executive function.

Open Community Pulse →

04 / CLAIM VS EVIDENCE

Where cognitive claims get stretched.

“Less anxiety means better cognition.”Reduced anxiety can improve subjective performance or task engagement without proving a direct cognitive-enhancing effect.
“Feeling focused proves attention improved.”Subjective focus and objective attention testing are different outcomes.
“Animal memory data prove a human nootropic effect.”Preclinical learning or memory findings can support a hypothesis but do not establish human efficacy.
“A neuroactive peptide is automatically a nootropic.”Neuroactivity describes biology, not whether attention, memory or executive function improve in humans.
The editorial rule: name the endpoint—anxiety, mood, memory, attention, vigilance or executive function—and do not let one stand in for another.
05 / BEYOND THE INDEX

The outcome is bigger than peptides.

Cognitive performance is shaped by sleep, stress, cardiovascular health, metabolic health, psychiatric health, training and environment as much as by any single molecule.

Future coverage can follow sleep architecture, stress physiology, neuroimaging, digital cognitive testing, stimulants, psychiatric therapeutics, wearables, brain-computer interfaces and evidence-based behavioral interventions.

SleepStressNeuroimagingCognitive testingWearablesPsychiatryStimulantsBrain-computer interfaces
06 / KEEP READING

Follow the endpoint, not the label.

Neuropeptide Signal

Selank

High community interest around calm focus and anxiety, with a human evidence base that should be interpreted carefully.

Explore Selank →

Sleep & Cognition

DSIP

A useful reminder that names and mechanisms can sound more definitive than the underlying human evidence.

Explore DSIP →

Broader Context

Sleep Outcome Hub

Sleep quality, sleep architecture and next-day cognition are deeply linked—but distinct outcomes.

Explore Sleep →

Research System

The Peptide Index

Compare Human Evidence, Community Signal, The Gap and regulatory status across the broader library.

Open the Index →

Editorial note: BIOHACKING. EVOLVED. is an educational publication, not a medical provider. This Outcome Hub does not provide diagnosis, dosing, sourcing or treatment guidance. Cognitive claims should distinguish subjective experience, psychiatric symptoms and objective performance outcomes.